Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease?

Size: px
Start display at page:

Download "Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease?"

Transcription

1 Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease? David A. Wolk, M.D. Assistant Director Penn Memory Center Assistant Professor of Neurology University of Pennsylvania

2 5 Million

3 Clinical and Pathological Course of AD Clinical State Normal Pre-Clinical AD Cognitive No No Symptoms State Symptoms? Pathologic State No Disease Plaques Early Changes MCI Mild Symptoms y p Mild-ModMod Changes AD Mild-Severe Symptoms y p Mod-Severe Changes Tangles

4 Aging Versus AD

5 Age Associated Cognitive Impairment Park and Reuter Lorenz, Ann Rev. Psychol., 2009

6 Aging Versus Preclinical/Prodromal AD Quantitative differences E.g. Face name memory test Specificity dependent of degree of age related and AD related change Qualitative differences?

7 Topographic p Selectivity of AD Mesulam, 1990

8 Braak & Braak. Acta Neuropath, 1991

9 Doctor Who

10 Downton Abbey Sir Richard Carlisle (Ian Glenn)

11 Dual Process Models of Recognition Memory Two distinct memory processes Familiarity (item memory) Acontextual sense of prior encounter Quantitative Relatively automatic process Recollection (associative, relational) Detailed retrieval, including spatial and temporal context mental time travel Qualitative Controlled Process

12 Proposed Spatial and Temporal Dissociation of Recollection and Familiarity it Neuroanatomy Recollection: Hippocampus, Frontal control networks Familiarity: Perirhinal cortex/lateral entorhinal area Timing Recollection: Slower Familiarity: Faster

13 Binding of Items and Context Model Eichenbaum et al., Ann Rev Neurosci, 2007

14 What Drives Memory Loss with Normal Aging? Buckner, Neuron, 2004 Small et al., Nature Neuroscience, 2012

15 Is Familiarity Selectively Impaired in MCI (prodromal lad)? Normal aging: g recollection impaired, familiarity intact MCI: Predict familiarity (and recollection) should be impaired Alternative: If familiarity and recollection on strength continuum, expect relative sparing of familiarity

16 16 MCI; 21 Controls Three process estimation paradigms Wolk et al., Neuropsychologia, 2008

17 Process-Dissociation Paradigms Intact OLD Rearranged NEW Novel NEW pr = p( Old Intact) p( Old Rearranged) pf = p( Old Rearranged)/(1 pr)

18 Wolk et al., Neuropsychologia, 2008

19 Recollection and Familiarity Impaired in MCI (NC: n=81; MCI: n=65) Recollection Familiarity p< p< Control-Referenced z-scores p<0.001 Wolk et al., Neuropsychologia, 2013

20 Is Familiarity Spared in Normal Aging? (YC: n=18; OC: n=81) Recollection p < Familiarity Wolk et al., Neuropsychologia, 2013

21 Petersen Criteria for MCI (now referred dto as amnestic MCI) Memory complaint (preferably corroborated by informant) Episodic Memory impairment for age and education Largely intact general cognitive function Essentially preserved activities of daily living Do not meet criteria for dementia

22 Amnestic MCI Enriched in patients with AD pathology Specialty Clinics 10 to 15% Conversion to clinical AD per year 1 3% in cognitively normal adults 50 80% over 5 years Community Studies (PAQUID, MoVIES) Lower conversion rate (4 to 8%/year) Reversion to normal (10 to 40% over 2 years)

23 Amyloid Imaging 55-65% PiB positive in most studies of MCI Wolk and Klunk, 2009

24 Does Familiarity Discriminates MCI Based on Amyloid Status (n=22)? Recollection Familiarity p<0.05

25 Limited Neuropsychological py Data Familiarity Recollection Rugg and Yonelinas, TICS, 2002 Bowles et al., PNAS, 2007 Guedj et al., Neuropsychologia, 2010

26 Relationship to MTL Volumes Examined relationship of recollection and familiarity estimates with structure Hippocampus Extrahippocampal MTL (PRC, ERC, PHG) Automated Labeling Pathway (Wu et al., 2006; Andreescu et al., 2007) Wolk et al., Hippocampus, 2011

27 * * Wolk et al., Hippocampus, 2011

28 Correlates of Memory in AD Patients from ADNI ADNI participants with clinical AD diagnosis Mean MMSE: 23.3 ±2.0 (SD) MRI of sufficient quality (n=146) MRI analysis Disease specific ROI s (hippocampus, PRC/ERC) Correlate with standard memory measures differentially dependent on recollection/familiarity

29 Memory Measure Rey Auditory Verbal Learning Test (AVLT) 15 words 5 Immediate memory (learning) trials List B immediate memory 5 minute delayed recall 30 minute delayed recall Recognition memory test

30 AD Cohort from ADNI (n=146) AVLT Delayed Memory Measures Recollection Recall ** ** Familiarity Recollection Recognition * Wolk & Dickerson, NeuroImage, 2011

31 Pure Familiarity Recognition discrimination controlled for free recall Wolk and Dickerson, NeuroImage, 2011

32 Interim Summary Familiarity-based memory is spared as part of normal age-associated cognitive decline Familiarity is dependent on integrity of perirhinal cortex (ERC?) Consistent with early involvement of PRC in AD pathologic process, familiarity-based memory appears sensitive and specific to prodromal AD Is familiarity-based memory sensitive to preclinical AD?

33 Preclinical Alzheimer s Disease 25-30% of CN adults with AD molecular biomarker profile Consistent t with autopsy data Morris et al., Annals of Neurology, 2010

34 Cortical Signature of AD Dickerson et al., Cerebral Cortex, 2011

35 Abnormal Amyloid (PiB) Function Psychometrics Biomar rker Magnit tude Normal Normal Presymptomatic MCI Dementia Clinical disease stage Modified from Jack et al., 2010

36 Abnormal Amyloid (PiB) Function Biomar rker Magnit tude Psychometrics Brain Structure (MRI) Normal Normal Presymptomatic MCI Dementia Clinical disease stage Modified from Jack et al., 2010

37 Abnormal Amyloid (PiB) Function Biomar rker Magnit tude Psychometrics Brain Structure (MRI) Brain Physiology (PET) Normal Normal Presymptomatic MCI Dementia Clinical disease stage Modified from Jack et al., 2010

38 Does Evidence of AD Specific Atrophy Predict tdecline in CN Adults ADNI healthy controls with adequate 1.5 T MRI (n=159) Mean AD signature measure converted to z score > 1 SD bl below mean ADsig hi thin (high h risk ik group) Within 1 SD of mean ADsig Average > 1 SD above mean ADsig thick (lowest risk group) 3 year follow up a priori cutoffs of functional (> 1.0 increase in CDR Sum of Boxes) and cognitive decline (> 1 SD decline)

39 Cortical Thinning in Signature of AD regions predicts decline and CSF AD profile in Cognitively Normal Adults Dickerson and Wolk, Neurology, 2012

40 Relationship of AD Cortical Signature with Recollection/Familiarity β=.55, p< β=.37, p< 0.05 Wolk et al., Neuropsychologia, 2013

41 Summary Biomarkers of neurodegeneration may be valuable in temporal prediction in preclinical phases beyond amyloid status Preclinical disease may be associated with subtle cognitive change Familiarity as possible screening measure? Familiarity as cognitive outcome measure in preclinical trials

42 Collaborators Penn Paul Yushkevich Sandy Das MGH/Harvard Pitt Brad Dickerson John Detre Steve Arnold Steve DeKosky Lauren Mancuso Howard Aizenstein Dasha Kliot Eric Signoff Kti Katie Manning Kathryn Dunfee Funding: K23AG028018; R01AG040271; P30AG010124; Alzheimer s Association

Primary Endpoints in Alzheimer s Dementia

Primary Endpoints in Alzheimer s Dementia Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in

More information

CRITERIA FOR AD DEMENTIA June 11, 2010

CRITERIA FOR AD DEMENTIA June 11, 2010 CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester

More information

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Community Geriatric Mental Health Model of Continuum of Cognition with Aging Normal Mild cognitive

More information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate

More information

Biomarkers for Alzheimer's Disease in Down Syndrome

Biomarkers for Alzheimer's Disease in Down Syndrome Biomarkers for Alzheimer's Disease in Down Syndrome Brad Christian, Ph.D. Waisman Laboratory for Brain Imaging Outline Rationale for Studying AD in Down Syndrome Background of Alzheimer s Disease Biomarkers

More information

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease

MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can

More information

Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project

Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project Tohoku J. Exp. Med., 2008, 215, 125-131 MCI and Dementia in a Community 125 Review Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project KENICHI

More information

Diseases of the Nervous System. Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University

Diseases of the Nervous System. Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University Diseases of the Nervous System Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University Outline A. Stress-related Disorders 1. Emotional Circuitry: Key Components 2. The Hypothalamic

More information

Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D.

Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D. Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D. Melbourne Australia March 28, 2012 Synarc Experience and Expertise Largest imaging service provider dedicated to clinical

More information

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI)

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Mike R. Schoenberg, PhD, ABPP-CN Diplomate, American Board of Clinical Neuropsychology Licensed Psychologist Departments of Psychiatry

More information

Human recognition memory: a cognitive neuroscience perspective

Human recognition memory: a cognitive neuroscience perspective Review TRENDS in Cognitive Sciences Vol.7 No.7 July 2003 313 Human recognition memory: a cognitive neuroscience perspective Michael D. Rugg 1 and Andrew P. Yonelinas 2 1 Institute of Cognitive Neuroscience

More information

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease 2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease Dylan Wint, M.D. ALZHEIMER DISEASE Dylan Wint, M.D. Lou Ruvo Center for Brain Health DEFINITIONS Cognitive related to thinking,

More information

Cognitive Interventions for Mild Cognitive Impairment

Cognitive Interventions for Mild Cognitive Impairment Cognitive Interventions for Mild Cognitive Impairment Kelly Murphy, PhD Neuropsychology & Cognitive Health, Baycrest Health Sciences Psychology Department, University of Toronto Aging & Speech Communication:

More information

Alzheimer s disease. What is Alzheimer s disease?

Alzheimer s disease. What is Alzheimer s disease? Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible

More information

Alzheimer s & Dementia 7 (2011) 280 292

Alzheimer s & Dementia 7 (2011) 280 292 Alzheimer s & Dementia 7 (2011) 280 292 Toward defining the preclinical stages of Alzheimer s disease: Recommendations from the National Institute on Aging-Alzheimer s Association workgroups on diagnostic

More information

WMS III to WMS IV: Rationale for Change

WMS III to WMS IV: Rationale for Change Pearson Clinical Assessment 19500 Bulverde Rd San Antonio, TX, 28759 Telephone: 800 627 7271 www.pearsonassessments.com WMS III to WMS IV: Rationale for Change Since the publication of the Wechsler Memory

More information

GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY BE AN EFFECTIVE TREATMENT FOR ALZHEIMER S DISEASE AND VASCULAR DEMENTIA

GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY BE AN EFFECTIVE TREATMENT FOR ALZHEIMER S DISEASE AND VASCULAR DEMENTIA CONTACT: Alzheimer s Association AAIC newsroom, 202-249-4002, [email protected] Niles Frantz, Alzheimer s Association, 312-335-5777, [email protected] GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY

More information

Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD

Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD Normal and Abnormal Aging and the Brain Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD The myth of cognitive decline The myth of cognitive decline Individual change varies Individual change varies

More information

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

Social Security Disability Insurance and young onset dementia: A guide for employers and employees Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll

More information

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College Bedside cognitive examination beyond the MMSE Dr Richard Perry Dept of Neurosciences Imperial College Overview Initial observations Cognitive rating scales Assessing cognitive domains Memory Language Visuospatial

More information

ANXIETY & COGNITIVE IMPAIRMENT

ANXIETY & COGNITIVE IMPAIRMENT ANXIETY & COGNITIVE IMPAIRMENT Dr. Sherri Hayden, Ph.D., R. Psych. Neuropsychologist, UBC Hospital Clinic for Alzheimer Disease & Related Disorders Clinical Assistant Professor, UBC Department of Medicine,

More information

Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease

Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease Eleonora (Nora) Lad, MD, PhD Assistant Professor of Ophthalmology, Vitreoretinal diseases Duke Center for Macular Diseases Duke University

More information

Automatic Morphological Analysis of the Medial Temporal Lobe

Automatic Morphological Analysis of the Medial Temporal Lobe Automatic Morphological Analysis of the Medial Temporal Lobe Neuroimaging analysis applied to the diagnosis and prognosis of the Alzheimer s disease. Andrea Chincarini, INFN Genova Clinical aspects of

More information

Clinical Research Infrastructure

Clinical Research Infrastructure Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice

More information

Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment

Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Teresa Leung Therapist Prince of Wales Hospital 7 th May, 2012 Outline of Presentation Introduction Study Objectives,

More information

Gene E. Alexander, Ph.D. Elsa Baena

Gene E. Alexander, Ph.D. Elsa Baena Gene E. Alexander, Ph.D. Professor and Director, Brain Imaging Behavior & Aging Lab Department of Psychology and Phone: 520-626-1704 Email: [email protected] Dr. Alexander s research interests

More information

Dementia: Delivering the Diagnosis

Dementia: Delivering the Diagnosis Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology University of Utah Diagnosing Dementia

More information

Brain Structures That are Involved with Memory

Brain Structures That are Involved with Memory Early Theories of Brain Structures That are Involved with Psychology 372 Sensation Sensory Attention Rehearsal STM Storage Retrieval Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio

More information

Predicting the future progression of dementia. Ashish Raj, PhD

Predicting the future progression of dementia. Ashish Raj, PhD Business Presentation Predicting the future progression of dementia Ashish Raj, PhD Founder and CEO Associate Professor of Computer Science in Radiology Director, IDEAL Laboratory Associate Professor of

More information

AQT-D. A Quick Test of Cognitive Speed. AQT-D is designed for dementia screening.

AQT-D. A Quick Test of Cognitive Speed. AQT-D is designed for dementia screening. AQT-D A Quick Test of Cognitive Speed AQT-D is designed for dementia screening. A General Introduction to AQT AQT 1 is an objective, reliable and standardized screening test designed to measure cognitive

More information

Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE

Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE L Ignoto, il Mistero, stimolano il pensiero, sono indispensabili al poeta ed all artista, aprono alla creatività. L Ignoto, il Mistero,

More information

Copywrite - Eric Freitag, Psy.D., 2012

Copywrite - Eric Freitag, Psy.D., 2012 Diagnosis, Intervention and Care for Patients With Cognitive Impairment Eric J. Freitag, Psy.D, FACPN Diplomate, American College of Professional Neuropsychology Mt. Diablo Memory Center Founder/Executive

More information

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia By Scott Knight, Director, SLR Diagnostics & Assessments, a division of Sibley & Associates Inc., and Konstantine

More information

Collaborative Care for Alzheimer s Disease

Collaborative Care for Alzheimer s Disease The Health Care Workforce for Older Americans: Promoting Team Care Institute of Medicine Symposium October 2008 Collaborative Care for Alzheimer s Disease Christopher M. Callahan, MD Cornelius and Yvonne

More information

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia

More information

2016 Programs & Information

2016 Programs & Information Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia

More information

COGNITION IN AGING AND AGE-RELATED DISEASE

COGNITION IN AGING AND AGE-RELATED DISEASE COGNITION IN AGING AND AGE-RELATED DISEASE Elizabeth A. Kensinger Department of Psychology Boston College Address correspondence to: Elizabeth A. Kensinger Department of Psychology, McGuinn Hall Boston

More information

Neuropsychology Research Program: Thomas P. Ross, Ph.D.

Neuropsychology Research Program: Thomas P. Ross, Ph.D. Neuropsychology Research Program: Thomas P. Ross, Ph.D. My primary research program is devoted to the psychometric examination of neuropsychological tests of executive functioning, and other abilities

More information

Alzheimer s & Dementia 9 (2013) e1 e16

Alzheimer s & Dementia 9 (2013) e1 e16 Alzheimer s & Dementia 9 (2013) e1 e16 Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer s Association

More information

2 Neurons. 4 The Brain: Cortex

2 Neurons. 4 The Brain: Cortex 1 Neuroscience 2 Neurons output integration axon cell body, membrane potential Frontal planning control auditory episodes soma motor Temporal Parietal action language objects space vision Occipital inputs

More information

CONTE Summer Lab Experience Application

CONTE Summer Lab Experience Application CONTE Summer Lab Experience Application When preparing your application for funding from the CONTE Summer Lab Experience through the Undergraduate Program in Neuroscience, please read these instructions

More information

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have

More information

Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease

Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions

More information

DOTT. GIOVANNI CARLESIMO ELENCO DELLE PUBBLICAZIONI ANNI 2008-2013

DOTT. GIOVANNI CARLESIMO ELENCO DELLE PUBBLICAZIONI ANNI 2008-2013 DOTT. GIOVANNI CARLESIMO ELENCO DELLE PUBBLICAZIONI ANNI 2008-2013 1. P. Turriziani, M. Oliveri, S. Salerno, F. Costanzo, G. Koch, C. Caltagirone, G. A. Carlesimo. Recognition memory and prefrontal cortex:

More information

Attention, memory and learning and acquired brain injury. Vicki Anderson. Jamie M. Attention & learning: an information processing model

Attention, memory and learning and acquired brain injury. Vicki Anderson. Jamie M. Attention & learning: an information processing model Attention, memory and learning and acquired brain injury Vicki Anderson Jamie M. Childhood acquired amnesia Attention & learning: an information processing model MANAGEMENT Organising, problem solving

More information

Diagnosis and Initial Management of Cognitive Disorders

Diagnosis and Initial Management of Cognitive Disorders Diagnosis and Initial Management of Cognitive Disorders January 29, 2016 Kelly Garrett, PhD Cathleen Obray, MD, MHS Neurosciences Clinical Program Cognitive Care Team None Disclosures Neurosciences Clinical

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Business Office: 598 Airport Boulevard Suite 1400 Morrisville NC 27560 Contact: [email protected] Phone: 888.750.6941 Fax: 888.650.6795 www.cognitrax.com Diseases of the

More information

Applied Nursing Research

Applied Nursing Research Applied Nursing Research 26 (2013) 71 75 Contents lists available at SciVerse ScienceDirect Applied Nursing Research journal homepage: www.elsevier.com/locate/apnr Clinical Methods Impact of missing data

More information

Simposio Internacional: International Symposium Murray Grossman

Simposio Internacional: International Symposium Murray Grossman Murray Grossman Office Address: Department of Neurology - Gates 3 Hospital of the University of Pennsylvania Philadelphia, PA 19104-4283 If you are not a U.S. citizen please indicate the type of visa you

More information

THEORIES OF NEUROLOGICAL AGING AND DEMENTIA

THEORIES OF NEUROLOGICAL AGING AND DEMENTIA THEORIES OF NEUROLOGICAL AGING AND DEMENTIA Aging Overview The primary care physician must advise middle-age and older patients about ways to age successfully. Dementia is a common disabling illness that

More information

How To Navigate Early-Stage Alzheimer s Disease

How To Navigate Early-Stage Alzheimer s Disease How To Navigate Early-Stage Alzheimer s Disease PRODUCED BY What We Can Expect Unless there is a cure, over the next 20 years, as Baby Boomers turn 65, the age after which Alzheimer s disease becomes most

More information

FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov

FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov FUNCTIONAL EEG ANALYZE IN AUTISM Dr. Plamen Dimitrov Preamble Autism or Autistic Spectrum Disorders (ASD) is a mental developmental disorder, manifested in the early childhood and is characterized by qualitative

More information

Attention & Memory Deficits in TBI Patients. An Overview

Attention & Memory Deficits in TBI Patients. An Overview Attention & Memory Deficits in TBI Patients An Overview References Chan, R., et.al.. (2003). Are there sub-types of attentional deficits in patients with persisting post- concussive symptoms? A cluster

More information

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive

More information

1 st December 2009. Cardiff Crown Court. Dear. Claimant: Maurice Kirk Date of Birth: 12 th March 1945

1 st December 2009. Cardiff Crown Court. Dear. Claimant: Maurice Kirk Date of Birth: 12 th March 1945 Ref: PMK/MT 1 st December 2009 Cardiff Crown Court Dear Claimant: Maurice Kirk Date of Birth: 12 th March 1945 I have been instructed by Yorkshire Law Solicitors to comment on the SPECT scan images undertaken

More information

Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment

Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment Cameron J. Camp, Ph.D. Director of Research and Development Center for Applied Research in Dementia [email protected] www.cen4ard.com

More information

Pradeep Redddy Raamana

Pradeep Redddy Raamana Pradeep Redddy Raamana Research Scientist at Simon Fraser University [email protected] Summary Highlights 8 years of experience in machine learning, data mining and statistical modelling. 6 years of experience

More information

Scandinavian Bio-Business Seminar, Zürich. Presentation 10 February 2016 Håkon Sæterøy, CEO

Scandinavian Bio-Business Seminar, Zürich. Presentation 10 February 2016 Håkon Sæterøy, CEO Scandinavian Bio-Business Seminar, Zürich Presentation 10 February 2016 Håkon Sæterøy, CEO Clinical need 75 m patients WW A global estimate of 75m patients with Mild Cognitive Impairment (MCI) who may

More information

Alzheimer s and Depression: What is the Connection?

Alzheimer s and Depression: What is the Connection? Alzheimer s and Depression: What is the Connection? Ladson Hinton MD Professor and Director of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Director, Education Core, Alzheimer

More information

WISC IV and Children s Memory Scale

WISC IV and Children s Memory Scale TECHNICAL REPORT #5 WISC IV and Children s Memory Scale Lisa W. Drozdick James Holdnack Eric Rolfhus Larry Weiss Assessment of declarative memory functions is an important component of neuropsychological,

More information

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013 Overview Neuropsychological Assessment in Stroke Brandon Ally, PhD Department of Neurology What is Neuropsychology Stroke Specific Neuropsychology Neuropsychological Domains Case Study What is Neuropsychology?

More information

No Dementia Stage 2: Very Mild Cognitive Decline

No Dementia Stage 2: Very Mild Cognitive Decline Stages of Dementia Health professionals sometimes discuss dementia in "stages," which refers to how far a person's dementia has progressed. Defining a person's disease stage helps physicians determine

More information

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault [email protected]

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault [email protected] Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late

More information

Local Clinical Trials

Local Clinical Trials Local Clinical Trials The Alzheimer s Association, Connecticut Chapter does not officially endorse any specific research study. The following information regarding clinical trials is provided as a service

More information

Disclosures. Case: Ms. K. Case: Ms. K. Dementia: Considering When to Start, Stop, and Continue Medications 4/23/15. * Nothing to disclose

Disclosures. Case: Ms. K. Case: Ms. K. Dementia: Considering When to Start, Stop, and Continue Medications 4/23/15. * Nothing to disclose Dementia: Considering When to Start, Stop, and Continue Medications * Nothing to disclose Disclosures Lianne Hirano, MD UW Division of Gerontology & Geriatric Medicine 4/23/15 Current Concepts in Drug

More information

Dementia Causes and Neuropsychological Evaluation of the Older Adult

Dementia Causes and Neuropsychological Evaluation of the Older Adult Dementia Causes and Neuropsychological Evaluation of the Older Adult Laurie N. Culp, Ph.D. Pate and Culp Psychological Assoc. 2440 Lawrenceville Highway Suite 200 Decatur, GA 30033 678-595-0062 [email protected]

More information

Early Changes in the Brain Proteome Associated with Alzheimer's Disease Risk

Early Changes in the Brain Proteome Associated with Alzheimer's Disease Risk Early Changes in the Brain Proteome Associated with Alzheimer's Disease Risk Nicholas T. Seyfried Assistant Professor Departments of Biochemistry and Neurology Alzheimer s Disease Research Center Emory

More information

Auditory memory and cerebral reorganization in post-linguistically deaf adults

Auditory memory and cerebral reorganization in post-linguistically deaf adults Auditory memory and cerebral reorganization in post-linguistically deaf adults Implications for cochlear implantation outcome D Lazard, HJ Lee, E Truy, AL Giraud Ecole Normale Supérieure, Inserm U960,

More information

Cognitive Neuroscience. Questions. Multiple Methods. Electrophysiology. Multiple Methods. Approaches to Thinking about the Mind

Cognitive Neuroscience. Questions. Multiple Methods. Electrophysiology. Multiple Methods. Approaches to Thinking about the Mind Cognitive Neuroscience Approaches to Thinking about the Mind Cognitive Neuroscience Evolutionary Approach Sept 20-22, 2004 Interdisciplinary approach Rapidly changing How does the brain enable cognition?

More information

Encyclopedia of School Psychology Neuropsychological Assessment

Encyclopedia of School Psychology Neuropsychological Assessment Encyclopedia of School Psychology Neuropsychological Assessment Contributors: Cynthia A. Riccio & Kelly Pizzitola Jarratt Edited by: Steven W. Lee Book Title: Encyclopedia of School Psychology Chapter

More information

advancing magnetic resonance imaging and medical data analysis

advancing magnetic resonance imaging and medical data analysis advancing magnetic resonance imaging and medical data analysis INFN - CSN5 CdS - Luglio 2015 Sezione di Genova 2015-2017 objectives Image reconstruction, artifacts and noise management O.1 Components RF

More information

Staging and Treatment of Dementia

Staging and Treatment of Dementia Staging and Treatment of Dementia Ami Hall DO 10/25/14 1 Objectives What are the two most common types of dementias seen in a primary care office How are they staged What treatments are available Definition

More information

In conjunction with clinical history, structural

In conjunction with clinical history, structural A QUICK GUIDE FOR NEUROIMAGING OF COMMON DEMENTIAS SEEN IN CLINICAL PRACTICE PRINT THIS ARTICLE David F. Tang-Wai, MDCM, FRCPC, assistant professor of neurology and geriatric medicine at the University

More information